Sarcoidosis — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Use protocolized short-acting octreotide with anesthesia and neuroendocrine-team planning
The best answer is “Use protocolized short-acting octreotide with anesthesia and neuroendocrine-team planning”. Tumor manipulation can provoke massive mediator release with hypotension, bronchospasm and arrhythmia. Peri-procedural short-acting octreotide availability and coordinated planning are standard preventive measures; stopping somatostatin therapy or using unrelated single agents leaves the mechanism untreated.
Reference: Canadian consensus recommendations for gastroenteropancreatic neuroendocrine tumours: https://pmc.ncbi.nlm.nih.gov/articles/PMC2880904/